So did we! Hepatitis (A, B, C, D, & E) are viruses with B & C being the most Infectious and prevalent globally. As we belatedly pay respect to 2017’s World Hepatitis Day, it’s important to note that approximately 325 million people suffer from chronic Hepatitis. It impacts people across the globe: from Pakistan, to Africa and the baby boomers in the US. The World Health Organization published a global health sector strategy in 2016 to prevent and control the virus in the global population.
As with HIV/AIDS, Spot On Sciences has been increasingly active, working with a number of organizations to validate the use of the HemaSpot device for the collection of Dried Blood Spot (DBS) enabling easier testing across the diagnostic cascade: screening, confirmatory, viral load, as well as genotyping.
In the near future, Spot On Sciences will be launching a new global health initiative to help address the diagnosis and treatment of infectious disease across the globe. We’re proud to be a part of this effort to help grow awareness and be part of the arsenal that fights debilitating
Spot On Sciences, Inc, of course, owes a lot to Dr. Guthrie. He’s the one responsible for the collection of whole blood on specially designed filter paper, commonly known as “Guthrie cards.” He also developed the well known bacterial inhibition assay used to screen infants for phenylketonuria (known as PKU) at birth. This newborn screening program for PKU has been in place since the early 1960’s and is still being used around the world as a way to test for a number of treatable conditions.
Wikis and web-sources agree that Guthrie’s motivation for developing the Guthrie test was a personal one. He became interested in causes and prevention of mental retardation after his son, John, was born disabled in 1947. Later, when his niece was diagnosed with PKU he turned his attention to preventable causes.
Today,DBS continues to be used in newborn screening thanks, in large part, to major advances in technology that make it possible to screen for many conditions using only one test. In the U.S., a system of testing is in place that allows the majority of states to screen for over fifty conditions.
Thank you, Dr. Guthrie!